ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2

Ekaterina V. Kalashnikova, Alexey S. Revenko, Abigael T. Gemo, Nicolas P. Andrews, Clifford G Tepper, June X Zou, Robert Cardiff, Alexander D Borowsky, Hongwu Chen

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2'. Together they form a unique fingerprint.

Medicine & Life Sciences